A Phase 2, Double-blind, Randomized Controlled Trial of PROSTVAC in Prostate Cancer Patients on Active Surveillance-Reference-Cited by-同舟云学术

A Phase 2, Double-blind, Randomized Controlled Trial of PROSTVAC in Prostate Cancer Patients on Active Surveillance

Published:2022-12 Issue: Volume: Page:
ISSN:2405-4569
Container-title:European Urology Focus
language:en
Short-container-title:European Urology Focus

Author:

Parsons J. Kellogg,Pinto Peter A.,Pavlovich Christian P.,Uchio Edward,Nguyen Mike N.,Kim Hyung L.,Gulley James L.,Sater Houssein Abdul,Jamieson Christina,Hsu Chiu-Hsieh,Wojtowicz Malgorzata,House Margaret,Schlom Jeffrey,Donahue Renee N.,Dahut William L.,Madan Ravi A.,Bailey Shania,Centuori Sara,Bauman Julie E.,Parnes Howard L.,Chow H.-H. Sherry

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Urology

Reference11 articles.

1. Immunotherapy for localized prostate cancer: the next frontier?;Patel;Urol Clin North Am,2020

2. Immunotherapy of prostate cancer: facts and hopes;Bilusic;Clin Cancer Res,2017

3. Phase III trial of PROSTVAC in asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer;Gulley;J Clin Oncol,2019

4. Impact of tumour volume on the potential efficacy of therapeutic vaccines;Gulley;Curr Oncol,2011

5. Endpoints, patient selection, and biomarkers in the design of clinical trials for cancer vaccines;Bilusic;Cancer Immunol Immunother,2012

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate cancer stem cells and their targeted therapies;Frontiers in Cell and Developmental Biology;2024-08-08

2. Nonsurgical Interventions to Prevent Disease Progression in Prostate Cancer Patients on Active Surveillance: A Systematic Review and Meta-analysis;European Urology Oncology;2023-10